Suppliers and packagers for STEGLUJAN

STEGLUJAN

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Msd Sub Merck	STEGLUJAN	ertugliflozin; sitagliptin phosphate	TABLET;ORAL	209805	NDA	Merck Sharp & Dohme LLC	0006-5367-03	30 TABLET, FILM COATED in 1 BOTTLE (0006-5367-03)	2017-12-19
Msd Sub Merck	STEGLUJAN	ertugliflozin; sitagliptin phosphate	TABLET;ORAL	209805	NDA	Merck Sharp & Dohme LLC	0006-5367-06	90 TABLET, FILM COATED in 1 BOTTLE (0006-5367-06)	2017-12-19
Msd Sub Merck	STEGLUJAN	ertugliflozin; sitagliptin phosphate	TABLET;ORAL	209805	NDA	Merck Sharp & Dohme LLC	0006-5367-07	500 TABLET, FILM COATED in 1 BOTTLE (0006-5367-07)	2017-12-19
Msd Sub Merck	STEGLUJAN	ertugliflozin; sitagliptin phosphate	TABLET;ORAL	209805	NDA	Merck Sharp & Dohme LLC	0006-5367-09	2 BOTTLE in 1 CARTON (0006-5367-09) / 7 TABLET, FILM COATED in 1 BOTTLE (0006-5367-08)	2017-12-19
Msd Sub Merck	STEGLUJAN	ertugliflozin; sitagliptin phosphate	TABLET;ORAL	209805	NDA	Merck Sharp & Dohme LLC	0006-5368-03	30 TABLET, FILM COATED in 1 BOTTLE (0006-5368-03)	2017-12-19

Who Supplies STEGLUJAN (Ertugliflozin/Linagliptin)?

Last updated: April 30, 2026

What is STEGLUJAN and what drug substances does it contain?

STEGLUJAN is a fixed-dose combination tablet containing:

• Ertugliflozin (SGLT2 inhibitor)
• Linagliptin (DPP-4 inhibitor)

Which suppliers make STEGLUJAN’s active ingredients (APIs)?

No complete, citable supplier list for STEGLUJAN APIs (ertugliflozin and linagliptin) can be produced from the information available in this chat.

Which suppliers manufacture STEGLUJAN tablets (finished dose) for market?

No complete, citable finished-product manufacturer/supplier list for STEGLUJAN can be produced from the information available in this chat.

What labels typically disclose STEGLUJAN suppliers?

Drug supplier identity for both API and finished dose is usually disclosed via:

• US prescribing information (Highlights, “Manufactured for/By,” and sections listing manufacturer details)
• EMA EPAR (European assessment reports) and product manufacturing information
• Regulatory submissions and public patent estate documents (when they include manufacturing capability or named entities)

Key Takeaways

• STEGLUJAN contains ertugliflozin + linagliptin.
• A complete, citable list of STEGLUJAN suppliers (APIs and finished tablets) is not available from the information provided in this chat.
• Supplier identification requires direct use of prescribing/EPAR manufacturer sections or equivalent regulatory documents.

FAQs

1. Who makes STEGLUJAN tablets?
   Not determinable from the information provided in this chat.

2. Who supplies the ertugliflozin API for STEGLUJAN?
   Not determinable from the information provided in this chat.

3. Who supplies the linagliptin API for STEGLUJAN?
   Not determinable from the information provided in this chat.

4. Where on the label is the manufacturing supplier usually listed?
   Commonly in sections such as “Manufactured for” / “Manufactured by” in US prescribing information.

5. Do patents list STEGLUJAN manufacturing suppliers?
   Some do, but this chat contains no citable patent/document text for supplier extraction.

References

[1] No sources were provided in the chat for STEGLUJAN supplier extraction.